Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors
In Brief: HHS Names Deputy HCFA Administrator; M.D. Anderson’s Error-Free Record Honored
FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs
Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years
Receipt Dates Clarified For AIDS-Cancers PA
Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio
Grants Funding; NCI Restores Paylines To Last Year’s Levels
AHCPR Funds Centers to Review Practice
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









